Predicting endometrial cancer type with MRI and pathology
Part of Cancer, Women’s health & pregnancy clinical trials.
This study uses MRI scans and tissue samples to predict the molecular type and outlook of endometrial cancer, which may help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with endometrial cancer (a type of uterine cancer).
- You are between 18 and 80 years old.
- You have not had any other cancers.
- You have had an MRI scan within 2 weeks before starting treatment.
- You have not received any cancer treatment (like surgery or chemotherapy) before this study.
- You have not had a biopsy of the uterus lining before the MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will look at how certain genetic changes (in the TP53 gene and in chromosome stability) affect endometrial cancer that has a specific molecular profile (pMMR/MSS and no POLE mutation). It aims to understand why these tumors behave the way they do.
This trial studies whether special scans (PET/MRI) can help predict how well endometrial cancer patients will do. You may be asked to get these scans before surgery, and your results may help classify your cancer risk.
This study looks at whether knowing the genetic profile (molecular classification) of your endometrial cancer can help guide fertility-sparing treatment. It aims to improve outcomes for young patients who want to preserve their ability to have children.
This study uses a special type of MRI called diffusion-weighted imaging (DWI) to look at the endometrium (the lining of the uterus) and help tell the difference between benign and cancerous growths. The results will be compared to a biopsy to see how accurate the MRI is.
This study uses special PET scans to better see and understand pelvic tumors. It may help doctors plan treatment more accurately. You may be able to join if you have a pelvic tumor and can have surgery or a biopsy.
This trial is testing whether a computer model powered by artificial intelligence can better predict outcomes for people with endometrial cancer or related conditions. It uses patient data and tissue samples to see if the model can help doctors choose the best care.
Hear when a new Endometrial Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.